DR's orders: Human antibody kills tumors by direct signaling
- 1 August 2002
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 8 (8) , 781-783
- https://doi.org/10.1038/nm0802-781
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cellsNature Medicine, 2002
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular LymphomaClinical Lymphoma, 2001
- Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2000
- Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 proteinBlood, 1994
- T-Cell Tumor Elimination as a Result of T-Cell Receptor-Mediated ActivationScience, 1987
- Lymphoma models for B-cell activation and toleranceCellular Immunology, 1985